Thirona spins out the Retina business to pursue long-term growth plans
Summary
Thirona specialises in artificial intelligence for lung and retinal image analysis allowing for precise quantification of abnormalities related to pulmonary and eye diseases. The high-precision analyses contribute to development of innovative solutions for screening, diagnostics, and personalized patient treatment. Thirona BV will continue to concentrate on AI-powered solutions for precision medicine in lung diseases, in partnership with pharmaceutical, med-tech and clinical care integration companies. “The Class IIa European MDR CE certified RetCAD is already being integrated by all major fundus camera providers such as iCare, Topcon, Canon, Tomey and Nidek. More dedication will allow us to speed up the expansion to other channels and to grow our leadership position globally.” “This formal separation ensures that both companies are optimally positioned to pursue their growth plans and maximizes the ability to create value in their respective markets," said Guido Geerts, Partner and co-CEO of Thirona BV.